NANOTECHNOLOGY IN BIOTECHNOLOGY: INNOVATIONS IN DRUG DELIVERY SYSTEMS AND DIAGNOSTICS

Abstract

Nanotechnology has revolutionized the field of biotechnology by enabling unprecedented precision in drug delivery and diagnostics. Through the manipulation of materials at the nanoscale, it has become possible to overcome traditional therapeutic limitations such as poor solubility, rapid degradation, and nonspecific targeting. This research investigates innovative applications of nanoparticle-based systems—including liposomes, dendrimers, micelles, and polymeric nanoparticles—designed to enhance therapeutic efficacy and diagnostic sensitivity.A systematic simulation-driven methodology was employed to analyze nanoparticle performance across a variety of biomedical scenarios. Controlled release kinetics, targeting efficiency, biocompatibility, diagnostic accuracy, and cost-efficiency were examined through mathematical modeling and experimental validation pipelines. The study integrated sustained drug release equations and nanoparticle engineering principles to map drug behavior in chronic and genetic disease contexts.Results demonstrated that polymeric nanoparticles and dendrimers significantly improved therapeutic outcomes across cancer, diabetes, and genetic disorders due to superior targeting capabilities and prolonged release profiles. Diagnostic systems utilizing gold nanoparticles and quantum dots showed enhanced sensitivity and specificity when compared to conventional methods. Moreover, gene therapy delivery platforms using nanoparticles achieved consistent success rates above 80%, while maintaining low variability across trials.The findings confirm that nanotechnology not only advances drug efficacy and precision diagnostics but also facilitates personalization in therapeutic regimens. However, challenges such as regulatory ambiguity, scale-up reproducibility, and long-term safety must be addressed to enable widespread clinical integration. This research underscores the transformative potential of nanotechnology in reshaping modern medicine and paves the way for synergistic innovations through integration with artificial intelligence and gene editing technologies. The convergence of these domains holds promise for ushering in an era of truly individualized and responsive healthcare systems..